AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion

Why did oil prices surge after Israel struck Iran? How will Nippon Steel's US Steel acquisition impact trade? What caused recent stock market drops amid Middle East tensions? Why are Amazon and Walmart considering issuing stablecoins? How did Israel's attack affect global energy markets? What led to GameStop’s convertible bond offering increase? Why did Tesla delay its robotaxi service launch?

AstraZeneca Inks Research Pact With China's CSPC Pharmaceuticals Focused On AI-Driven Research, Valued Up To $5.33 Billion

benzinga.com/markets/large-cap/25/06/45924585/astrazeneca-inks-research-pact-with-chinas-cspc-pharmaceuticals-focused-on-ai-driven-research-v

On Friday, AstraZeneca Plc (NASDAQ:AZN) entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.
Per the agreement, AstraZeneca and CSPC agree to discover and develop preclinical candidates for multiple targets with the potential to…

This story appeared on benzinga.com, 2025-06-13 13:08:23.